Concepedia

Carlos Fierro

CF

Statistics

Publications

16

Citations

473

H-Index

13

Active since

2019

Affiliations

Johnson County Clin-Trials (United States)(Current)

Moderna Therapeutics (United States)

Meridian Clinical Research

Janssen (Netherlands)

Janssen (Belgium)

Carlos Fierro is an author at Johnson County Clin-Trials (United States) specializing in infectious diseases, veterinary medicine, and immunization.

Publications per year

2019–2025

16

Publications

16

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

Nadine C. Salisch, Kathryn E. Stephenson, Kristi L. Williams et al. · Annals of Internal Medicine · 2021 · 80 citations

, , +17

Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial

Carlos Fierro, Daniel C. Brune, Marian Shaw et al. · The Journal of Infectious Diseases · 2024 · 58 citations · Full text

, , +16

Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents

Germán Áñez, Lisa M. Dunkle, Cynthia L. Gay et al. · JAMA Network Open · 2023 · 50 citations · Full text

, , +17

Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults

Brandon Essink, Carlos Fierro, Jeffrey B. Rosen et al. · Vaccine · 2019 · 43 citations · Full text

, , +17

Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial

James Wassil, Maggie Sisti, Jeff Fairman et al. · The Lancet Infectious Diseases · 2023 · 31 citations

, , +17

1–5 of 16